Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The "Hoddle Muddle": using faith healers and other complementary therapists in sports medicine.

British journal of sports medicine·1998
Same author

The rise and fall of complementary medicine.

Journal of the Royal Society of Medicine·1998
Same author

The prevalence of complementary/alternative medicine in cancer: a systematic review.

Cancer·1998
Same author

Does moderate alcohol consumption affect fertility? Follow up study among couples planning first pregnancy.

BMJ (Clinical research ed.)·1998
Same author

[Phytotherapy. 1. Use in diseases of the locomotor system].

Fortschritte der Medizin·1998
Same author

[Phytotherapy. 5: Gastrointestinal tract (2)].

Fortschritte der Medizin·1998

Related Experiment Video

Updated: Jul 7, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Hawthorn extract for treating chronic heart failure.

M H Pittler, R Guo, E Ernst

    The Cochrane Database of Systematic Reviews
    |February 7, 2008
    PubMed
    Summary

    Hawthorn extract significantly improves symptoms and physiological outcomes for chronic heart failure patients when used alongside conventional treatments. This herbal remedy offers benefits with minimal side effects.

    Area of Science:

    • Cardiology
    • Pharmacology
    • Herbal Medicine

    Background:

    • Hawthorn extract is recognized for its potential in managing chronic heart failure.
    • German Commission E approved hawthorn leaf and flower extracts for heart failure (NYHA stage II).

    Purpose of the Study:

    • To evaluate the efficacy and safety of hawthorn extract versus placebo in treating chronic heart failure.
    • Assessed benefits and harms through double-blind, randomized clinical trials.

    Main Methods:

    • Conducted a comprehensive literature search across multiple databases (CENTRAL, MEDLINE, EMBASE, CINAHL, AMED).
    • Included randomized, double-blind, placebo-controlled trials using hawthorn leaf and flower extract monopreparations.
    • Performed independent study selection, data extraction, and quality assessment by two reviewers.

    Related Experiment Videos

    Last Updated: Jul 7, 2026

    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
    10:05

    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

    Published on: July 7, 2016

    Main Results:

    • Meta-analysis of 10 trials (855 patients) showed hawthorn extract improved maximal workload and exercise tolerance.
    • Hawthorn treatment led to a beneficial decrease in the pressure-heart rate product, an indicator of cardiac oxygen consumption.
    • Significant improvements were observed in symptoms like shortness of breath and fatigue compared to placebo.
    • Adverse events were infrequent, mild, and transient, including nausea and dizziness.

    Conclusions:

    • Hawthorn extract demonstrates significant benefits in symptom management and physiological outcomes for chronic heart failure.
    • It is effective as an adjunctive therapy to conventional treatments for heart failure.
    • The study supports the use of hawthorn extract for improving quality of life in heart failure patients.